From the pharmacophore to the homology model of the benzodiazepine receptor: the indolyglyoxylamides affair
- PMID: 22204482
- DOI: 10.2174/156802612799078702
From the pharmacophore to the homology model of the benzodiazepine receptor: the indolyglyoxylamides affair
Abstract
Interaction between the so-called benzodiazepine receptor (BzR) and the chemically heterogeneous class of its ligands is still one of the most challenging objects of theoretical studies. In the mid-90s our group began to collaborate with Prof. Antonio Da Settimo and coworkers to a project of synthesis and biological evaluation of indolylglyoxylamides designed as BzR ligands. Herein we review our efforts in designing these compounds and in interpreting their structureaffinity relationships. Our investigations were carried out for years by adopting the pharmacophore/topological model for BzR ligands set up by Cook's group. In an attempt to rationalize some puzzling structure-affinity relationships we speculated in 1998 that our ligands interact with the BzR by assuming one of two alternative binding modes (called "A" and "B") depending on whether or not they were substituted at the 5-position of the indole nucleus. Such a model received support from a considerable amount of experimental data accumulated throughout our researches. About a decade later, docking calculations performed on a homology-built model of the 1 BzR subtype were found in agreement with the hypothesis of mode A and mode B of binding accessible to 5-H and, respectively, 5-Cl/NO2 indole derivatives.
Similar articles
-
Geometrically constrained derivatives of indolylglyoxylamides as ligands binding the GABAA/BzR complex.Curr Top Med Chem. 2012;12(4):312-20. doi: 10.2174/156802612799078829. Curr Top Med Chem. 2012. PMID: 22204489 Review.
-
Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents.Curr Top Med Chem. 2012;12(4):286-311. doi: 10.2174/156802612799078847. Curr Top Med Chem. 2012. PMID: 22204484 Review.
-
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects.Curr Top Med Chem. 2012;12(4):333-51. doi: 10.2174/156802612799078766. Curr Top Med Chem. 2012. PMID: 22204487 Review.
-
Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationships.J Med Chem. 2001 Jul 5;44(14):2286-97. doi: 10.1021/jm010827j. J Med Chem. 2001. PMID: 11428922
-
Computational studies on translocator protein (TSPO) and its ligands.Curr Top Med Chem. 2012;12(4):352-9. doi: 10.2174/156802612799078667. Curr Top Med Chem. 2012. PMID: 22204485 Review.
Cited by
-
Identification of novel indole derivatives acting as inhibitors of the Keap1-Nrf2 interaction.J Enzyme Inhib Med Chem. 2019 Dec;34(1):1152-1157. doi: 10.1080/14756366.2019.1623209. J Enzyme Inhib Med Chem. 2019. PMID: 31179771 Free PMC article.
-
Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A2B AR Physio-Pathological Implications.Front Pharmacol. 2021 Mar 24;12:652121. doi: 10.3389/fphar.2021.652121. eCollection 2021. Front Pharmacol. 2021. PMID: 33841166 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources